- PDLIM7 and CDH18 regulate the turnover of MDM2 during CDK4/6 inhibitor therapy-induced senescence. Oncogene. 2018 Academic Article GET IT
- CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought. Cancer Cell. 2018 In Process GET IT
- ATRX is a regulator of therapy induced senescence in human cells. Nature Communications. 2017 Academic Article GET IT
MDM2 turnover and expression of ATRX determine the choice between quiescence and senescence in response to CDK4 inhibition.
Times cited: 25